Proactive Investors - Run By Investors For Investors
Market: AIM:EVG
52-week High/Low: 26.00p / 12.15p
Sector: Pharma & Biotech
Market Cap: 19.36M
Evgen Pharma

Evgen Pharma

Evgen Pharma plc, a clinical stage drug development company focused on the treatment of cancer and neurological conditions.

Evgen Pharma

Interactive graph

col 3
col 4
col 5
col 6

Evgen Pharma RNS Announcements

Date Epic Announcement
15/05/2018 EVG Price Monitoring Extension
14/05/2018 EVG Upcoming Investor Presentations
02/05/2018 EVG Grant of further European patent
26/04/2018 EVG Second Price Monitoring Extn
26/04/2018 EVG Price Monitoring Extension
24/04/2018 EVG Presentation at World Orphan Drug Congress USA
20/03/2018 EVG Research Collaboration with Imperial College
05/03/2018 EVG Update on Novel Sulforaphane Analogues
15/01/2018 EVG Poster Presentation of SFX-01 Mechanistic Data
10/01/2018 EVG Notification of Major Interest in Shares
05/01/2018 EVG Notification of Major Interest in Shares
05/01/2018 EVG Notification of Major Interest in Shares
02/01/2018 EVG Total Voting Rights
28/12/2017 EVG Result of General Meeting
22/12/2017 EVG Grant of Options
13/12/2017 EVG Collaboration with King's College London
11/12/2017 EVG Hardman Res.: Funded to the end of Phase II trials
08/12/2017 EVG Placing and Notice of General Meeting
08/12/2017 EVG Interim Results
23/11/2017 EVG Second Price Monitoring Extn
23/11/2017 EVG Price Monitoring Extension
04/10/2017 EVG First European Patent Grant
31/08/2017 EVG Issue of Equity and Total Voting Rights
02/08/2017 EVG SFX-01 data published in Peer Reviewed Journal
26/07/2017 EVG AGM Statement
11/07/2017 EVG Charity-funded Study of SFX-01 in TNBC
21/06/2017 EVG Posting of Annual Report and AGM Notice
21/06/2017 EVG Hardman Research: Making clinical progress
13/06/2017 EVG Full Year Results
01/06/2017 EVG Compassionate Use Programme and Trials Update

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use